tiprankstipranks

Dennis Langer Insider Profile

4 Followers
Dennis Langer, Director at Dicerna Pharma, holds 77.04K shares in Dicerna Pharma (Ticker: DRNA), holds 0.00 shares in Pernix Therapeutics (Ticker: PTXTQ), holds ― shares in Eterna Therapeutics (Ticker: ERNA).
tipranks
Dennis Langer

Dennis Langer
Dicerna Pharma (DRNA)
Director

Ranked #63,655 out of 98,624 Corporate Insiders

Profitable Transactions

67%
4 out of 6 Profitable Transactions

Average Return

-7.30%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
94.92%
5.08%
0.00%
0.00%
A breakdown of Dennis Langer's holdings

Insider Roles

Myriad Genetics
(MYGN)
Director
Delcath Systems
(DCTH)
Director
Eterna Therapeutics
(ERNA)
Director
Quoin Pharmaceuticals
(QNRX)
Director
Roles that Dennis Langer holds in companies

Most Profitable Insider Trade

Stock:
Myriad Genetics
(MYGN)
Rating:Informative Sell
Date:Jun 01, 2018 - Jun 01, 2019
Return:+37.20%
The most profitable trade made by Dennis Langer

Dennis Langer's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
DRNA
Dicerna Pharma
Aug 17, 2018
Uninformative Sell
613.46K
$2.94M
PTXTQ
Pernix Therapeutics
$0.00
Eterna Therapeutics
Director
Quoin Pharmaceuticals
Director
Myriad Genetics
Jun 03, 2022
Director
Uninformative Buy
$2.08M
Delcath Systems
Jun 12, 2015
Director
Uninformative Buy
$111.20K
AUXL
Auxilium
Jan 05, 2010
Uninformative Buy
9.98K
List of latest transactions for each holding click on a transaction to see Dennis Langer's performance on stock

Dennis Langer insider profile FAQ

What is the percentage of profitable transactions made by Dennis Langer?
The percentage of profitable transactions made by Dennis Langer is 67%.
    What is the average return per transaction made by Dennis Langer?
    The average return per transaction made by Dennis Langer is -7.30%.
      What stocks does Dennis Langer hold?
      Dennis Langer holds: DRNA, PTXTQ, ERNA, QNRX, MYGN, DCTH, AUXL stocks.
        What was Dennis Langer’s latest transaction?
        Dennis Langer latest transaction was an Uninformative Sell of $613.46K.
          What was Dennis Langer's most profitable transaction?
          Dennis Langer’s most profitable transaction was an Informative Sell of MYGN stock on June 1, 2018. The return on the trade was 37.20%.
            What is Dennis Langer's role in Dicerna Pharma?
            Dennis Langer's role in Dicerna Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.